News details
Information title
Nasdaq warns Oncothyreon; ATS buys majority share of Ganymed;
Published on Thursday 21 August 2008 - 17:07 Summary :
> Nasdaq is warning Oncothyreon that it has to be compliant with capital requirements by September 15 to prevent its move from the Global Market to the Capital Market. Report > ATS has bought out a...
Read more
http://www.fiercebiotech.com/news/frontpage
Website description
Get the latest news on the biotech industry, biotech companies, FDA approval and clinical research. Sign up today for the biotech industry
